Agency: NIH/NIMH
Agency Award Number: R01

To establish the utility of the functional battery for measuring HIV-related functional impairments in Spanish speakers.

Agency: NIH/NIMH
Agency Award Number: R21

Test the feasibility of using the PIB PET ligand to detect b-amyloid in the brains of HIV patients and compare the imaging results to neuropsychiatric examination, and compare the abundance and distribution of beta-amyloid in autopsy brain tissues to other markers of neurodegeneration associated with HIV in the brain.

Agency: NIH/NIMH/FIC
Agency Award Number: R21

To demonstrate feasibility and help develop an infrastructure to perform neurobehavioral and virological studies in Romania, which may provide a unique insight in the future of HIV-associated NP impairment in long term-survivors on HAART.

Agency: Merck Pharm
Agency Award Number: 33132

This project will estimate the penetration of Raltegravir into the brain by
measuring its concentrations in CSF and estimate the antiviral effectiveness
in the brain of Raltegravir by measuring HIV RNA levels in CSF.

Agency: NIH/NIMH

Agency Award Number: R01NS051132

To identify and characterize immunologic determinants of HIV evolution in the CNS.